Keyphrases
Cancer Invasion
100%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
100%
AE105
100%
Quantitative PET
100%
Receptor Expression
35%
Expression Level
28%
Tumor Uptake
21%
Human Cancer
21%
5-fluorouracil (5-FU)
14%
Cancer Xenograft
14%
Clinical Setting
14%
PET Tracer
14%
Uptake Pattern
14%
Enzyme-linked Immunosorbent Assay (ELISA)
7%
Specific Radioactivity
7%
High Affinity
7%
Receptor Targets
7%
Therapy Types
7%
Peptide-based
7%
Cancer Xenograft Model
7%
18F-fluorodeoxyglucose (18F-FDG)
7%
Tumor Biology
7%
Receptor Sensitivity
7%
High Purity
7%
Personalized Therapy
7%
Poor Prognosis
7%
Small Animal PET
7%
In(III)
7%
Clinical Potential
7%
FDG Uptake
7%
Peptide Antagonist
7%
Invasive Cancer
7%
Xenograft Mouse Model
7%
Tumor
7%
Medicine and Dentistry
Polyethylene Terephthalate
100%
Urokinase Receptor
100%
Copper 64
100%
Tumor Invasion
100%
Tetraxetan
100%
Receptor Expression
35%
Neoplasm
28%
Tumor Xenograft
21%
Radioactive Tracer
21%
Fluorodeoxyglucose F 18
14%
Fluorouracil
14%
Biological Marker
7%
Receptor
7%
Tumor Biology
7%
Personalized Medicine
7%
Cancer
7%
Cancer Therapy
7%
Enzyme Linked Immunosorbent Assay
7%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Invasion
100%
Tetraxetan
100%
Copper 64
100%
Urokinase Receptor
100%
Polyethylene Terephthalate
100%
Neoplasm
35%
Malignant Neoplasm
28%
Tracer
21%
Fluorodeoxyglucose F 18
14%
Fluorouracil
14%
Receptor
7%
Enzyme-Linked Immunosorbent Assay
7%
Mouse Model
7%
Biological Marker
7%
Veterinary Science and Veterinary Medicine
Cancer
100%
Neoplasm
71%
Mouse
28%
Immunology and Microbiology
Urokinase Receptor
100%
Xenograft
21%
Peptide Receptor
7%
Peptides
7%
Mouse Model
7%
Radioactivity
7%
Enzyme-Linked Immunosorbent Assay
7%
Agricultural and Biological Sciences